These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6528089)

  • 1. Impact of early detection of breast cancer on adjuvant chemotherapy.
    Hartmann WH
    Recent Results Cancer Res; 1984; 96():30-3. PubMed ID: 6528089
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of prognostic factors to adjuvant chemotherapy in breast cancer.
    Bonadonna G; Valagussa P
    Recent Results Cancer Res; 1984; 96():34-45. PubMed ID: 6528090
    [No Abstract]   [Full Text] [Related]  

  • 3. Review: scientific basis of adjuvant chemotherapy in breast cancer.
    Griswold DP
    Recent Results Cancer Res; 1984; 96():46-7. PubMed ID: 6528091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
    Zhang B; Cao WF; Zhao HM; Song YQ; Ning LS; Niu Y; Hao XS; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):790-4. PubMed ID: 20021837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant chemotherapy of breast cancer: persistent controversy].
    Nagel GA
    Klin Wochenschr; 1984 Feb; 62(4):145-8. PubMed ID: 6708397
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
    Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
    Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant chemotherapy in operable breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1984 Jun; 109(26):1034-43. PubMed ID: 6734462
    [No Abstract]   [Full Text] [Related]  

  • 9. Nodal micrometastases status--will it influence decisions on surgical and adjuvant treatment for breast cancer?
    Harissis H; Fatouros M
    Ann Surg Oncol; 2008 Apr; 15(4):1256-7; author reply 1258. PubMed ID: 18239968
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
    Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
    Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 12. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contralateral axillary drainage in breast tumor recurrence].
    Sabaté M; Roca I; Córdoba O; Kysiel N; Rubio I; Castell J
    Rev Esp Med Nucl; 2011; 30(5):327-8. PubMed ID: 21514976
    [No Abstract]   [Full Text] [Related]  

  • 14. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preclinical scientific basis for adjuvant chemotherapy in breast cancer.
    Griswold DP; Laster WR; Trader MW; Dykes DJ
    Recent Results Cancer Res; 1984; 96():1-7. PubMed ID: 6528086
    [No Abstract]   [Full Text] [Related]  

  • 16. Axillary surgery in breast cancer: the beginning of the end.
    Dumitru D; Khan A; Catanuto G; Rocco N; Nava MB; Benson JR
    Minerva Chir; 2018 Jun; 73(3):314-321. PubMed ID: 29589679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
    Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
    Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 19. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
    Callcut RA; Breslin TM
    Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
    [No Abstract]   [Full Text] [Related]  

  • 20. [Necessity of adjuvant therapy after radical mastectomy based on a study of patients with negative nodes, who have recurrent breast cancer].
    Asagoe T; Yamoto H; Nemoto A; Shikata J; Aoki A; Nakayama R; Tashiro Y
    Gan No Rinsho; 1988 Jan; 34(1):41-4. PubMed ID: 3339848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.